{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T19:08:00Z","timestamp":1789412880797,"version":"build-2803163510"},"reference-count":26,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,3]]},"DOI":"10.1097\/mcg.0b013e3182582cdb","type":"journal-article","created":{"date-parts":[[2012,12,24]],"date-time":"2012-12-24T23:58:41Z","timestamp":1356393521000},"page":"246-251","source":"Crossref","is-referenced-by-count":42,"title":["Neopterin Concentration as an Index of Disease Activity in Crohn\u2019s Disease and Ulcerative Colitis"],"prefix":"10.1097","volume":"47","author":[{"given":"Nisreen","family":"Husain","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ken","family":"Tokoro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanna M.","family":"Popov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stanley J.","family":"Naides","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary J.","family":"Kwasny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan L.","family":"Buchman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R2-13-20210305","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1111\/j.1572-0241.2007.01556.x","article-title":"Noninvasive markers of assessment of intestinal inflammation in inflammatory bowel disease: performance of fecal lactoferrin, calprotectin, and PMN-elastase, CRP, and clinical indices.","volume":"103","author":"Langhorst","year":"2008","journal-title":"Am J Gastroenterol"},{"key":"R3-13-20210305","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1080\/00365520500217118","article-title":"Clinically active Crohns disease in the presence of a low C-reactive protein.","volume":"41","author":"Florin","year":"2006","journal-title":"Scan J Gastroenterol"},{"key":"R4-13-20210305","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1002\/ibd.20178","article-title":"Assessment of endoscopic activity index and biological inflammatory markers in clinically active Crohns disease with normal C-reactive protein level.","volume":"13","author":"Denis","year":"2007","journal-title":"Inflamm Bowel Dis"},{"key":"R5-13-20210305","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1111\/j.1365-2036.2006.03184.x","article-title":"Review article: biological activity markers in inflammatory bowel disease.","volume":"25","author":"Desai","year":"2007","journal-title":"Aliment Pharmacol Ther"},{"key":"R6-13-20210305","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1007\/s10350-008-9310-8","article-title":"Review of fecal biomarkers in inflammatory bowel disease.","volume":"51","author":"Sutherland","year":"2008","journal-title":"Dis Colon Rectum"},{"key":"R7-13-20210305","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1007\/s11894-009-0074-7","article-title":"Diagnostic advances in inflammatory bowel disease (imaging and laboratory).","volume":"11","author":"Moscandrew","year":"2009","journal-title":"Curr Gastroenterol Rep"},{"key":"R8-13-20210305","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1007\/s11894-010-0145-9","article-title":"The status of diagnostic markers for inflammatory bowel disease.","volume":"12","author":"Beniwal","year":"2010","journal-title":"Curr Gastroenterol Rep"},{"key":"R9-13-20210305","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1016\/j.cgh.2008.06.010","article-title":"Relationships between disease activity and serum and fecal biomarkers in patients with Crohns disease.","volume":"6","author":"Jones","year":"2008","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R10-13-20210305","first-page":"706","article-title":"The role of neopterin in assessing disease activity in Crohns disease: classification and regression trees.","volume":"88","author":"Judmaier","year":"1993","journal-title":"Am J Gastroenterol"},{"key":"R11-13-20210305","first-page":"70","article-title":"Neopterin: biochemistry and clinical usefulness.","volume":"7","author":"Andert","year":"1995","journal-title":"J Int Fed Clin Chem"},{"key":"R12-13-20210305","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1515\/pteridines.1996.7.12.5","article-title":"The regulation of neopterin production by cytokines.","volume":"7","author":"Seki","year":"1996","journal-title":"Pteridines"},{"key":"R13-13-20210305","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1084\/jem.160.1.310","article-title":"Immune response associated production of neopterin. Release from macrophages primarily under control of interferon-gamma.","volume":"160","author":"Huber","year":"1983","journal-title":"J Exp Med"},{"key":"R14-13-20210305","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.4049\/jimmunol.130.3.1047","article-title":"Pteridines as a new marker to detect human T cells activated by allogeneic or modified self major histocompatability complex (MHC) determinants.","volume":"130","author":"Huber","year":"1983","journal-title":"J Immunol"},{"key":"R15-13-20210305","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1046\/j.1365-2249.2003.02251.x","article-title":"Homocysteine accumulates in supernatants of stimulated human peripheral blood mononuclear cells.","volume":"134","author":"Schroecksnadel","year":"2003","journal-title":"Clin Exp Immunol"},{"key":"R16-13-20210305","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/0009-8981(86)90094-X","article-title":"Urinary neopterin, a marker of clinical activity in patients with Crohns disease.","volume":"155","author":"Prior","year":"1986","journal-title":"Clin Chim Acta"},{"key":"R17-13-20210305","first-page":"47","article-title":"The level of neopterin in blood serum as one of the possible prognostic markers of Crohns disease activity.","volume":"140","author":"Konecny","year":"1996","journal-title":"Acta Univ Palacki Olomuc Fac Med"},{"key":"R18-13-20210305","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1002\/ibd.20510","article-title":"Urinary neopterin is a valuable tool in monitoring Crohns disease activity.","volume":"14","author":"Nancey","year":"2008","journal-title":"Inflamm Bowel Dis"},{"key":"R19-13-20210305","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.dld.2005.01.010","article-title":"Immune activation and nutritional status in adult Crohns disease patients.","volume":"37","author":"Reimund","year":"2005","journal-title":"Digestive Liver Dis"},{"key":"R20-13-20210305","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/S0171-2985(85)80080-2","article-title":"Neopterin as a new biochemical marker in the clinical assessment of ulcerative colitis.","volume":"170","author":"Niederwieser","year":"1985","journal-title":"Immunobiol"},{"key":"R21-13-20210305","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1097\/00005176-200408000-00005","article-title":"Intestinal inflammation measured by fecal neopterin in Gambian children with enteropathy: association with growth failure, Giardia lamblia, and intestinal permeability.","volume":"39","author":"Campbell","year":"2004","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"R22-13-20210305","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/S0140-6736(80)92767-1","article-title":"A simple index of Crohns disease activity.","volume":"1","author":"Harvey","year":"1980","journal-title":"Lancet"},{"key":"R23-13-20210305","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1136\/gut.43.1.29","article-title":"A simple clinical colitis activity index.","volume":"43","author":"Walmsley","year":"1988","journal-title":"Gut"},{"key":"R24-13-20210305","first-page":"502","article-title":"A simple index of Crohns disease activity. The Cape Town index.","volume":"68","author":"Wright","year":"1985","journal-title":"South African Med J"},{"key":"R25-13-20210305","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1016\/0016-5085(87)90621-4","article-title":"5-aminosalicylic acid enema in the treatment of distal ulcerative colitis, protosigmoiditis, and proctitis.","volume":"92","author":"Sutherland","year":"1987","journal-title":"Gastroenterology"},{"key":"R26-13-20210305","first-page":"22","article-title":"Activation of mononuclear cells in Crohns disease.","volume":"14","author":"Duclos","year":"1990","journal-title":"Gastroenterol Clin Biol"},{"key":"R27-13-20210305","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.1002\/ibd.20920","article-title":"Questions and answers on the role of fecal lactoferrin as a biological marker in inflammatory bowel disease.","volume":"15","author":"Gisbert","year":"2009","journal-title":"Inflamm Bowel Dis"}],"container-title":["Journal of Clinical Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MCG.0b013e3182582cdb","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,28]],"date-time":"2023-06-28T04:56:12Z","timestamp":1687928172000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00004836-201303000-00013"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,3]]},"references-count":26,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.1097\/mcg.0b013e3182582cdb","relation":{},"ISSN":["0192-0790"],"issn-type":[{"value":"0192-0790","type":"print"}],"subject":[],"published":{"date-parts":[[2013,3]]}}}